Patterns of Systemic Treatment for Psoriatic Arthritis in the <scp>US</scp>: 2004–2015

Abstract

In this large cohort of PsA patients with DMARD initiation, more than 40% were treated with a bDMARD. We found an increasing trend in treatment modification after use of the initial DMARD and a decreasing trend in complete DMARD discontinuation over the past decade.